- Latest available (Revised)
- Original (As adopted by EU)
2000/428/EC: Commission Decision of 4 July 2000 establishing diagnostic procedures, sampling methods and criteria for the evaluation of the results of laboratory tests for the confirmation and differential diagnosis of swine vesicular disease (notified under document number C(2000) 1805) (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
There are currently no known outstanding effects by UK legislation for 2000/428/EC: Commission Decision, CHAPTER IV.![]()
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
blood samples from the suspected pigs and in-contact pigs for serological testing; and
faecal samples from suspected pigs and from the floor of their pen and of adjacent pens for virological testing.
for epithelium samples and vesicular fluid:
if possible, at least 1g of epithelium tissue from an unruptured or recently ruptured vesicle must be collected. It is recommended that pigs are sedated before samples are collected both to avoid injury to personnel as well as for pig welfare,
if transport to the national laboratory is carried out immediately (less than three hours), epithelial samples can be transported dry and kept refrigerated. However, if the time taken is likely to exceed three hours, the samples must be placed in a small volume of transport medium consisting of equal amounts of glycerol and 0,04 M phosphate buffer or other equivalent buffer (hepes), so that the pH is maintained in the optimal range for foot and mouth disease virus survival (pH from 7,2 to 7,6). The transport medium must contain antibiotics for additional anti-microbial activity. Suitable antibiotics and their concentration per ml final are:
penicillin 1000 IU,
neomycin sulphate 100 IU,
polymyxin B sulphate 50 IU,
mycostatin 100 IU,
if vesicular fluid can be collected from an unruptured vesicle, this must be kept undiluted in a separate container;
for blood samples:
blood samples can be collected for serological or virological tests. However, generally they are collected only from pigs suspected to have recovered from clinical or subclinical infection for antibody detection, as epithelium, vesicular fluid and faecal samples from pigs showing clinical signs of disease are more suitable for virus detection than blood samples. It is recommended that whole blood samples are taken using vacutainers with no anticoagulant and that the vacutainers are transported unopened;
for faecal samples:
faecal samples from the floor of premises suspected to contain, or to have contained, pigs infected with swine vesicular disease or faecal swabs and faecal samples from suspected live pigs must be placed in strong, leak-proof containers.
Containers of suspected samples must be disinfected on the outside before being transported to the laboratory. Suitable disinfectants are:
sodium hydroxide (1:100 dilution),
formalin (1:9 dilution of a solution of formalin containing a minimum of 34 % formaldehyde), and
sodium hypochlorite (2 % available chlorine).
These disinfectants must be handled with care.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: